123 related articles for article (PubMed ID: 25982681)
21. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro.
Walsh MD; Luckie SM; Cummings MC; Antalis TM; McGuckin MA
Breast Cancer Res Treat; 1999 Dec; 58(3):255-66. PubMed ID: 10718487
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of MUC1 epithelial mucin expression in breast cancer.
McGuckin MA; Walsh MD; Hohn BG; Ward BG; Wright RG
Hum Pathol; 1995 Apr; 26(4):432-9. PubMed ID: 7705823
[TBL] [Abstract][Full Text] [Related]
24. Tissue and serum MUC1 mucin detection in breast cancer patients.
Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
[TBL] [Abstract][Full Text] [Related]
25. Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes.
Iizuka M; Nakanishi Y; Fuchinoue F; Maeda T; Murakami E; Obana Y; Enomoto K; Tani M; Sakurai K; Amano S; Masuda S
Cancer Sci; 2015 Mar; 106(3):307-14. PubMed ID: 25556893
[TBL] [Abstract][Full Text] [Related]
26. MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells.
Lacunza E; Baudis M; Colussi AG; Segal-Eiras A; Croce MV; Abba MC
Cancer Genet Cytogenet; 2010 Sep; 201(2):102-10. PubMed ID: 20682394
[TBL] [Abstract][Full Text] [Related]
27. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers.
Uchiyama S; Itoh H; Naganuma S; Nagaike K; Fukushima T; Tanaka H; Hamasuna R; Chijiiwa K; Kataoka H
Gut; 2007 Feb; 56(2):215-26. PubMed ID: 16809422
[TBL] [Abstract][Full Text] [Related]
29. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
30. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A
Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
32. The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells.
Gornowicz A; Bielawska A; Czarnomysy R; Gabryel-Porowska H; Muszyńska A; Bielawski K
Mol Cell Biochem; 2015 Oct; 408(1-2):103-13. PubMed ID: 26112902
[TBL] [Abstract][Full Text] [Related]
33. Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function.
Baruch A; Hartmann M; Zrihan-Licht S; Greenstein S; Burstein M; Keydar I; Weiss M; Smorodinsky N; Wreschner DH
Int J Cancer; 1997 May; 71(5):741-9. PubMed ID: 9180140
[TBL] [Abstract][Full Text] [Related]
34. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
35. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg DM; Gold DV
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3065s-3072s. PubMed ID: 10541345
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein.
Nassar H; Pansare V; Zhang H; Che M; Sakr W; Ali-Fehmi R; Grignon D; Sarkar F; Cheng J; Adsay V
Mod Pathol; 2004 Sep; 17(9):1045-50. PubMed ID: 15154007
[TBL] [Abstract][Full Text] [Related]
37. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of the MUC1 gene product in human cancers grown in scid mice.
Schumacher U; Adam E
J Histochem Cytochem; 1998 Jan; 46(1):127-34. PubMed ID: 9405502
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical staining patterns of type VI collagen in the normal, hyperplastic, and neoplastic adult male breast.
Magro G; Lanzafame S; Colombatti A
Pathologica; 1994 Apr; 86(2):142-5. PubMed ID: 7936755
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
